Recent Searches

    Verano Holdings Begins Trading on Cboe Canada

    By

    This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live

    Multi-state medical cannabis company Verano Holdings Corp. has announced that its Class A subordinate voting shares have now begun trading on Canada’s Neo Exchange Inc., operating as Cboe Canada (Cboe Canada).

    The Shares will trade in Canada on Cboe Canada under the same symbol “VRNO” and in the U.S. on the OTCQX under the same symbol “VRNOF.”

    The company has stated that the trading of its securities is not expected to be disrupted in any way and current shareholders do not need to take any action.

    George Archos, Verano Founder and Chief Executive Officer, commented: “In light of recent news and movement within the U.S. cannabis space, today’s listing on Cboe Canada, which is part of a global network of exchanges across 26 marketplaces, is an intentional and strategic decision.

    “We believe that this move positions Verano for continued growth and expansion as we evolve in tandem with the rapidly changing industry.

    “We see this as a winning combination for Verano and our shareholders.”

    Jos Schmitt, President and CEO of Cboe Canada, added: “This uplisting reflects the bold strategic plan at the heart of Verano’s operations. Graduating to a senior exchange positions Verano on a launch pad, at the ready for legislative progress on a federal level in the U.S..

    “We expect that Verano’s decision to list on Cboe Canada will provide them with the liquidity, investor exposure, and international benchmark eligibility needed to sharpen their competitive edge and continue to execute on their plans for growth.

    “We are honoured to share this milestone achievement with Verano and look forward to supporting them in the years to come.”

     

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.